Rhythm Pharmaceuticals buy Canaccord Genuity Group Inc.
Start price
02.03.23
/
50%
€21.20
Target price
02.03.24
€52.93
Performance (%)
85.85%
End price
03.03.24
€39.40
Summary
This prediction ended on 03.03.24 with a price of €39.40. The BUY prediction by Canaccord_Genuity_Gr for Rhythm Pharmaceuticals saw massive gains of 85.85%. Canaccord_Genuity_Gr has a follow-up prediction for Rhythm Pharmaceuticals where he still thinks Rhythm Pharmaceuticals is a Buy. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Rhythm Pharmaceuticals | -4.667% | -4.667% | 45.918% | 338.650% |
| iShares Core DAX® | 2,55 % | 0,56 % | 14,14 % | 49,14 % |
| iShares Nasdaq 100 | 2,74 % | -0,60 % | 30,37 % | 82,05 % |
| iShares Nikkei 225® | 6,58 % | 4,34 % | 49,37 % | 60,62 % |
| iShares S&P 500 | 1,93 % | -0,51 % | 24,26 % | 59,66 % |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target raised by analysts at Canaccord Genuity Group Inc. from $52.00 to $56.00. They now have a "buy" rating on the stock.
Ratings data for RYTM provided by MarketBeat
In the thread Trading Rhythm Pharmaceuticals
Die von Canaccord_Genuity_Gr gewählte maximale Laufzeit wurde überschritten
Current prediction by Canaccord_Genuity_Gr for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€81.50
02.03.26
02.03.26
€118.79
02.03.27
02.03.27
-11.66%
10.04.26
10.04.26
